GlassScriptPhysician profile
Christy M Wagner
NPI 1790778033
$7,614.73
in general payments reported to CMS, 2019-2025
42 companies · $734 in 2025
The $734 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,518 · 2020: $717 · 2021: $1,346 · 2022: $1,272 · 2023: $953 · 2024: $1,075 · 2025: $734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,761.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,172.50 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $792.71 | 2019-2025 | Evenity, Repatha, Repatha |
| Lilly USA, LLC | $735.76 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Abbvie INC. | $718.74 | 2019-2024 | Synthroid, Ubrelvy |
| Takeda Pharmaceuticals U.S.A., INC. | $517.90 | 2019-2025 | Trintellix |
| Pfizer INC. | $513.35 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $424.41 | 2019-2025 | Airsupra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $412.94 | 2019-2025 | Jardiance, Ofev |
| Teva Pharmaceuticals USA, INC. | $231.41 | 2019-2022 | |
| Abbott Laboratories | $202.94 | 2022-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $191.83 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $164.94 | 2022-2025 | Quviviq, Quviviq |
| Supernus Pharmaceuticals, INC. | $146.28 | 2023-2024 | Qelbree, Qelbree |
| Biohaven Pharmaceutical Holding Company LTD. | $129.81 | 2022 | |
| Sanofi-Aventis U.S. LLC | $119.08 | 2019-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christy Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.